What treatment is recommended for a patient with a nasolacrimal duct obstruction after a nasolacrimal duct stent (NLD) fell out 2.5 years post-trauma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Nasolacrimal Duct Obstruction After Stent Dislodgement

Dacryocystorhinostomy (DCR) surgery is the recommended treatment for a patient with nasolacrimal duct obstruction after a stent has fallen out 2.5 years post-trauma.

Assessment of the Current Condition

When evaluating a patient whose nasolacrimal duct pin/stent has fallen out after 2.5 years, the following assessment should be performed:

  • Functional evaluation of the nasolacrimal tear drainage system 1
  • Assessment for symptoms of epiphora (excessive tearing)
  • Examination for signs of infection or inflammation
  • Evaluation of the puncta and canaliculi for patency

Treatment Algorithm

  1. Confirm Nasolacrimal Duct Obstruction

    • Perform slit-lamp examination
    • Assess tear film and tear meniscus height
    • Consider diagnostic tests such as dye disappearance test or dacryocystography
  2. Determine Treatment Approach

    • For confirmed nasolacrimal duct obstruction after stent loss:
      • Primary recommendation: Dacryocystorhinostomy (DCR)
      • This is superior to attempting replacement of the stent, which has lower long-term success rates 2
  3. Surgical Considerations

    • External DCR has 85-95% success rate 2
    • Endonasal approaches may be considered to avoid external scarring
    • Concurrent management of any associated conditions (e.g., chronic dacryocystitis)

Rationale for DCR Over Stent Replacement

The evidence strongly favors DCR over stent replacement for several reasons:

  • Long-term success rates with polyurethane nasolacrimal stents are low compared to external DCR 2
  • Patients with stents often continue to experience tearing despite a patent lacrimal system 2
  • The stent has already been in place for 2.5 years, suggesting the underlying condition is not likely to resolve without definitive surgery
  • Many patients with nasolacrimal duct obstruction have concomitant conditions like chronic dacryocystitis that may need surgical addressing 1

Post-Operative Management

After DCR surgery:

  • Follow-up within 1-2 weeks to assess surgical site
  • Monitor for complete resolution of epiphora
  • Evaluate for potential complications such as:
    • Infection
    • Scarring of the surgical ostium
    • Recurrent obstruction

Potential Complications and Pitfalls

  • Stent Replacement Pitfalls: If stent replacement is attempted instead of DCR, be aware that:

    • Stent occlusion is a common complication 3
    • Blood-stained nasal discharge may occur 3
    • Long-term patency rates are lower than with DCR 2
  • DCR Complications to Monitor:

    • Bleeding
    • Infection
    • Scarring of the surgical ostium
    • Failure to resolve symptoms

Special Considerations

For patients who absolutely refuse surgery or are poor surgical candidates:

  • Consider balloon dacryoplasty as an intermediate option, though success rates are lower than DCR 4
  • Be aware that interventional procedures with new stent designs show technical success rates of 97.1%, but long-term success rates decline to 91.4% after 12 months 5

The evidence clearly demonstrates that external DCR provides the most reliable and durable solution for nasolacrimal duct obstruction after stent dislodgement, with success rates of 85-95% compared to the more modest long-term outcomes with stent replacement.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Nasolacrimal stent implantation: report of a case].

Arquivos brasileiros de oftalmologia, 2008

Research

[Clinical application of a new nasolacrimal stent].

Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 2001

Research

[Lacrimal duct stent for nasolacrimal duct obstruction].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.